Giessrigl et al discovered that fulvestrant causes resistance by modulating the expression of GPER and CDK6 through the involvement of methyltransferases, deacetylases, and the human SWItch/Sucrose nonfermentable chromatin remodeling complex in the HR+ BC cells.94 The gene discussed is GPER1; the disease is breast cancer.